bla

To boost the research in Alzheimer’s disease, Bill Gates
invested 50 million dollars to Dementia Discovery Fund in the search for the
cure in the underlying causes of Dementia as number of people is affected
globally.

Last December 2017, World Health Organization (WHO) announced
that the use of the substance can benefit humans without the risk of addiction and
it could treat Alzheimer’s disease, Crohn’s disease, certain forms of cancer,
Parkinson’s disease and other serious conditions. However, According to the
Philippines’ drug laws or Republic Act No.9165 — mostly adapted from the 1961
Single Convention on Narcotic Drugs, as amended by the 1972 Protocol of the
United Nations — has formalized that marijuana is a “dangerous drug.”

We Will Write a Custom Essay Specifically
For You For Only $13.90/page!


order now

We Will Write a Custom Essay Specifically
For You For Only $13.90/page!


order now

Another study suggest sleep disorder may increase risk of
developing Alzheimer’s disease, In ‘Obstructive Sleep Apnea Severity Affects
Amyloid Burden in Cognitively Normal Elderly: A Longitudinal Study’ reports
that sleep apnoea, a sleep disorder, in which breathing repeatedly stops and
starts such cases are snoring loudly and feeling tired even after a full
night’s sleep increases the presence of a toxic protein linked to Alzheimer’s
disease, called amyloid, in the brain. The researchers also found that sleep
apnoea appears to affect amyloid not just in the short term, but over a long
period of time. According to Dr James Pickett, Head of Research and Development
at Alzheimer’s Society, said that they need to dig deeper in finding out if any
of this could reduce the risk of developing dementia by participating trials of
treatments for sleep apnoea.

Another research conducted by Kaiser Permanente Northern
California health care system suggest middle-aged woman who developed high
blood pressure could increase the  risk
of dementia later in life than women who had stable, normal blood pressure
throughout these years. However, Dr Doug Brown, Director of Research at
Alzheimer’s Society, mentioned that there have been advances in how blood
pressure is treated – so it’s not clear how relevant the findings of this study
are to the present UK population because the study was only referring to the
blood pressure of people in Northern California in the 1960s and 70s.

 

 

A study in the journal Proceedings of the National Academy of
Sciences stated that an experimental blood test can identify accurately and
diagnose Alzheimer’s disease, the most common form of dementia. Using this
test, Alzheimer’s patients can be identified with up to 86% sensitivity and specificity.
(Sensitivity refers true positives and on otherhand, specificity refers to true
negatives which can be identified in the test.) According to the website for
the Alzheimer’s Society, a registered UK charity that funds research, doctors
diagnose the disease based only on a careful evaluation through a postmortem
examination of a patient’s brain.  On the
otherhand, Francis Martin, a professor in the School of Pharmacy and Biomedical
Sciences at the University of Central Lancashire in the United Kingdom said
that the new test’s “accuracy is markedly higher than other tests being
developed,”which can be a life-changing diagnosis for Alzheimers disease.

A new research finds that blood-thinning drugs may likely to
be associated with reduction in dementia as well as reducing the risk of stroke
in patients with atrial fibrillation (AF). The study was conducted as the
largest to examine the link between anticoagulant treatment and dementia in AF
patients, from Swedish registries for patients between 2006 and 2014. Researchers
have monitored the effect over a period of time and found that taking
anticoagulant drugs will prevent blood clots and had a 29% lower risk of
developing dementia in the near future. However, the large study but cannot
prove cause and effect according to  James
Pickett, Head of Research at Alzheimer’s Society. That’s why it’s important to
follow preliminary measures at the early age such as blood pressure in check,
balance diet and taking a regular exercise.

According to
Martinez, Population Commission (PopCom) statistics have indicated that from
the 2.9 percent of Filipinos beyond 65 years old almost a decade ago, the
elderly population has increased to 4.3 percent of total population from 2014
to 2015. In a result, there would be 490,000 Filipinos over 65 who have varying
types of dementia. In the same report estimates the 2015 costs in the
Philippines of dementia at $599 million, broken down as follows: medical costs,
$167 million; non-medical costs, $83 million; and informal care costs, $349
million at the average 2015 exchange rate of $1:
P45.5028, the average cost per year per Alzheimer’s patient is P90,552To boost the research in Alzheimer’s disease, Bill Gates
invested 50 million dollars to Dementia Discovery Fund in the search for the
cure in the underlying causes of Dementia as number of people is affected
globally.Last December 2017, World Health Organization (WHO) announced
that the use of the substance can benefit humans without the risk of addiction and
it could treat Alzheimer’s disease, Crohn’s disease, certain forms of cancer,
Parkinson’s disease and other serious conditions. However, According to the
Philippines’ drug laws or Republic Act No.9165 — mostly adapted from the 1961
Single Convention on Narcotic Drugs, as amended by the 1972 Protocol of the
United Nations — has formalized that marijuana is a “dangerous drug.”

Another study suggest sleep disorder may increase risk of
developing Alzheimer’s disease, In ‘Obstructive Sleep Apnea Severity Affects
Amyloid Burden in Cognitively Normal Elderly: A Longitudinal Study’ reports
that sleep apnoea, a sleep disorder, in which breathing repeatedly stops and
starts such cases are snoring loudly and feeling tired even after a full
night’s sleep increases the presence of a toxic protein linked to Alzheimer’s
disease, called amyloid, in the brain. The researchers also found that sleep
apnoea appears to affect amyloid not just in the short term, but over a long
period of time. According to Dr James Pickett, Head of Research and Development
at Alzheimer’s Society, said that they need to dig deeper in finding out if any
of this could reduce the risk of developing dementia by participating trials of
treatments for sleep apnoea.

Another research conducted by Kaiser Permanente Northern
California health care system suggest middle-aged woman who developed high
blood pressure could increase the  risk
of dementia later in life than women who had stable, normal blood pressure
throughout these years. However, Dr Doug Brown, Director of Research at
Alzheimer’s Society, mentioned that there have been advances in how blood
pressure is treated – so it’s not clear how relevant the findings of this study
are to the present UK population because the study was only referring to the
blood pressure of people in Northern California in the 1960s and 70s.

 

 

A study in the journal Proceedings of the National Academy of
Sciences stated that an experimental blood test can identify accurately and
diagnose Alzheimer’s disease, the most common form of dementia. Using this
test, Alzheimer’s patients can be identified with up to 86% sensitivity and specificity.
(Sensitivity refers true positives and on otherhand, specificity refers to true
negatives which can be identified in the test.) According to the website for
the Alzheimer’s Society, a registered UK charity that funds research, doctors
diagnose the disease based only on a careful evaluation through a postmortem
examination of a patient’s brain.  On the
otherhand, Francis Martin, a professor in the School of Pharmacy and Biomedical
Sciences at the University of Central Lancashire in the United Kingdom said
that the new test’s “accuracy is markedly higher than other tests being
developed,”which can be a life-changing diagnosis for Alzheimers disease.

A new research finds that blood-thinning drugs may likely to
be associated with reduction in dementia as well as reducing the risk of stroke
in patients with atrial fibrillation (AF). The study was conducted as the
largest to examine the link between anticoagulant treatment and dementia in AF
patients, from Swedish registries for patients between 2006 and 2014. Researchers
have monitored the effect over a period of time and found that taking
anticoagulant drugs will prevent blood clots and had a 29% lower risk of
developing dementia in the near future. However, the large study but cannot
prove cause and effect according to  James
Pickett, Head of Research at Alzheimer’s Society. That’s why it’s important to
follow preliminary measures at the early age such as blood pressure in check,
balance diet and taking a regular exercise.

According to
Martinez, Population Commission (PopCom) statistics have indicated that from
the 2.9 percent of Filipinos beyond 65 years old almost a decade ago, the
elderly population has increased to 4.3 percent of total population from 2014
to 2015. In a result, there would be 490,000 Filipinos over 65 who have varying
types of dementia. In the same report estimates the 2015 costs in the
Philippines of dementia at $599 million, broken down as follows: medical costs,
$167 million; non-medical costs, $83 million; and informal care costs, $349
million at the average 2015 exchange rate of $1:
P45.5028, the average cost per year per Alzheimer’s patient is P90,552